Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on June 1, 2008

Papers In Press, published online ahead of print March 3, 2008
J. Lipid Res., doi:10.1194/jlr.M700426-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M700426-JLR200v1
49/6/1195    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, L.-H.
Right arrow Articles by Kashyap, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, L.-H.
Right arrow Articles by Kashyap, M. L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on September 26, 2007
Revised on March 3, 2008
Accepted on March 3, 2008

Niacin inhibits surface expression of ATP synthase beta chain in hepG2 cells: Implications for raising HDL

Lin-Hua Zhang, Vaijinath S. Kamanna, Michael C. Zhang, and Moti L. Kashyap

Atherosclerosis Research Center, VA Healthcare System, Long Beach, Long Beach, CA 90822

Corresponding Author: linhua.zhang{at}va.gov;

Niacin is an effective agent for raising HDL, but its cellular target sites are largely unknown. We examined effects of niacin on the surface expression of ATP synthase ß chain, a newly described HDL/apoA-I receptor for HDL endocytosis, in HepG2 cells. Significant amount of immuno-detectable ß chain was observed on the surface of HepG2 cells, which was competitively displaced by apolipoprotain A-I. Niacin treatment reduced the surface expression of ß chain in HepG2 cells by ~27%, and decreased 125I-labeled HDL uptake up to ~35%. However, nicotinamide, a niacin metabolite that does not have clinical lipid effects, exhibited weaker inhibition on the ß chain cell surface expression, and failed to show inhibitory action on 125I-labeled HDL uptake. Furthermore, anti-ß chain antibody significantly reduced 125I-labeled HDL uptake, and abolished niacin’s inhibitory effect. Niacin did not change ß chain mRNA expression. These data suggest that niacin inhibits cell surface expression of the ATP synthase ß chain, leading to reduced hepatic removal of HDL protein, thus implicating a potential cellular target for niacin action to raise HDL.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
G.F. Watts and D.C. Chan
Of Mice and Men: Blowing Away the Cobwebs From the Mechanism of Action of Niacin on HDL Metabolism
Arterioscler. Thromb. Vasc. Biol., November 1, 2008; 28(11): 1892 - 1895.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement